<DOC>
	<DOCNO>NCT00916513</DOCNO>
	<brief_summary>The present European survey seek ass quality life satisfaction treatment people T2DM appreciate disease treatment variable include hypoglycaemia level glycaemic control . It also provide relevant information important aspect level correlation objective measure HbA1c health status , QoL satisfaction current treatment . Overall 5000 randomly select patient invited participate representative sample clinical practice pre-specified period . The study entail single patient visit . Patients agree study give inform consent complete questionnaire , combine retrospective note review &amp; HbA1c test , allow patient , disease treatment variable collect . An HbA1c test finger prick test measure glycosylated haemoglobin blood indicate level blood glucose last 8-12 week .</brief_summary>
	<brief_title>Quality Life Treatment Satisfaction People With Type 2 Diabetes : A European Survey</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>With T2DM , diagnose least 1 year prior entry study Currently treat diet , OAD ( ) and/or insulin change type OAD ( ) insulin previous three month Type 1 diabetes and/or history diabetic ketoacidosis Secondary diabetes ( include disease exocrine pancreas , endocrinopathies druginduced ) Treatment systemic glucocorticoid replacement therapy . Inhaled , local inject topical use glucocorticoid allow</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Treatment Satisfaction</keyword>
	<keyword>Quality Life</keyword>
	<keyword>HbA1c level goal</keyword>
	<keyword>Healthcare resource consumption</keyword>
</DOC>